Xtant Medical completed the acquisition of the Coflex Product line of Surgalign for $17m.

Xtant Medical, a medical technology company focused on surgical solutions for the treatment of spinal disorders, completed the acquisition of the Coflex Product line of Surgalign, a medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, for $17m. “We are thrilled to acquire the Coflex and Cofix product lines, which will help accelerate our top-line growth and position Xtant to achieve critical mass. Coupled with our less invasive Axle interspinous device and Silex SI Fusion product lines, Coflex augments our offering in the fast-growing segments of ASC and outpatient procedures. Aligning with our key growth pillars, this acquisition expands our footprint by adding new distributors and a significant number of trained surgeons to the Company’s network. We expect these products to add approximately $14m in annual revenue and attractive margins to enable Xtant to achieve profitability in the near future,” Sean Browne, Xtant Medical President and CEO.